Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
Neoadjuvante immuuntherapie blijvend succesvol bij dMMR darmkanker
jun 2024 | Immuuntherapie, Maag-darm-leveroncologie